Evidence map›Paper›PMID 34943256›Full record

ArticleBiology2021

In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization.

Jorge Aramburu, Raúl Antón, Junichi Fukamizu, Daiki Nozawa, Makoto Takahashi, Kouji Ozaki, Juan Carlos Ramos, Bruno Sangro, José Ignacio Bilbao, Kosuke Tomita and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Jorge AramburuTecnun Escuela de Ingeniería, Universidad de Navarra, 20018 Donostia-San Sebastián, Spain.ORCID 0000-0002-2911-3397
Raúl AntónTecnun Escuela de Ingeniería, Universidad de Navarra, 20018 Donostia-San Sebastián, Spain.
Junichi FukamizuTerumo Corporation, 3-20-2, Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1450, Japan.
Daiki NozawaTerumo Corporation, 3-20-2, Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1450, Japan.
Makoto TakahashiTerumo Medical Pranex, 1500 Inokuchi, Nakai, Ashigarakami 259-0151, Japan.
Kouji OzakiTerumo Medical Pranex, 1500 Inokuchi, Nakai, Ashigarakami 259-0151, Japan.
Juan Carlos RamosTecnun Escuela de Ingeniería, Universidad de Navarra, 20018 Donostia-San Sebastián, Spain.ORCID 0000-0002-2560-1051
Bruno SangroIdiSNA, Instituto de Investigación Sanitaria de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-4177-6417
José Ignacio BilbaoIdiSNA, Instituto de Investigación Sanitaria de Navarra, 31008 Pamplona, Spain.
Kosuke TomitaDepartment of Radiology, Tokai University Hachioji Hospital, Tokai University School of Medicine, 1838 Ishikawa-machi, Hachioji, Tokyo 192-0032, Japan.ORCID 0000-0002-4310-7487
Tomohiro MatsumotoDepartment of Radiology, Tokai University Hachioji Hospital, Tokai University School of Medicine, 1838 Ishikawa-machi, Hachioji, Tokyo 192-0032, Japan.
Terumitsu HasebeDepartment of Radiology, Tokai University Hachioji Hospital, Tokai University School of Medicine, 1838 Ishikawa-machi, Hachioji, Tokyo 192-0032, Japan.
Terumo (Japan) · JPNavarre Institute of Health Research · ESTokai University Hachioji Hospital · JPUniversidad de Navarra · ES

Funding

Terumo (Japan) HPE-2019-TIS02
6 · The paper itself

Abstract

backgroundBalloon-occluded transarterial chemoembolization (B-TACE) has emerged as a safe and effective procedure for patients with liver cancer, which is one of the deadliest types of cancer worldwide. B-TACE consist of the transcatheter intraarterial infusion of chemotherapeutic agents, followed by embolizing particles, and it is performed with a microballoon catheter that temporarily occludes a hepatic artery. B-TACE relies on the blood flow redistribution promoted by the balloon-occlusion. However, flow redistribution phenomenon is not yet well understood.

methodsThis study aims to present a simple in vitro model (IVM) where B-TACE can be simulated.

resultsBy visually analyzing the results of various clinically-realistic experiments, the IVM allows for the understanding of balloon-occlusion-related hemodynamic changes and the importance of the occlusion site.

conclusionThe IVM can be used as an educational tool to help clinicians better understand B-TACE treatments. This IVM could also serve as a base for a more sophisticated IVM to be used as a research tool.

Indexed as

B-TACEhemodynamicsin vitro modelingliver cancermicroballoon catheter

Identifiers

PMID34943256
PMCPMC8698760
OpenAlexW4200080864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.